Medical panel approves opioid use disorder for cannabis, DOH expected to approve

A medical advisory panel on Friday said, for the third time, opioid use disorder should be a qualifying condition for medical cannabis—but this time the cabinet secretary tasked with final approval is expected to agree. The New Mexico Medical Cannabis Advisory Board voted unanimously to add opioid addiction to the list of 22 conditions already allowed. Only four other states allow patients to use cannabis to help alleviate symptoms of opioid use disorder. Dr. Laura Brown, the board’s chair, signaled that the Department of Health is changing course when it comes to medical cannabis under newly appointed Secretary Kathyleen Kunkel. A Medical Cannabis Advisory Board meeting on March 29, 2019.